相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of thrombosis associated with antiphospholipid antibodies in immune thrombocytopenic Purpura: A single center retrospective study of 152 patients
Damien Fayard et al.
THROMBOSIS RESEARCH (2023)
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia
Thomas Pincez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2023)
The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia
Jing Liu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Expert Report on Immune Thrombocytopenia-Current Diagnostics and Treatment Recommendations from an Expert Group from Austria, Germany, and Switzerland
Axel Matzdorff et al.
ONCOLOGY RESEARCH AND TREATMENT (2023)
Increasing Prevalence of Antinuclear Antibodies in the United States
Gregg E. Dinse et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia
Soo Min Ahn et al.
ARTHRITIS RESEARCH & THERAPY (2022)
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
Martin Aringer et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
Yuan Liu et al.
LUPUS SCIENCE & MEDICINE (2021)
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years
Stephane Ducassou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study
Fang-Xiao Zhu et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry
Guillaume Moulis et al.
BLOOD ADVANCES (2020)
The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia
Yan-ming Wang et al.
HEMATOLOGY (2020)
Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study
Guillaume Le Guenno et al.
INTERNAL MEDICINE JOURNAL (2019)
Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance
Marie A. Hollenhorst et al.
BLOOD ADVANCES (2019)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert et al.
BLOOD ADVANCES (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD ADVANCES (2019)
Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004)
Gregg E. Dinse et al.
PLOS ONE (2017)
Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study
Manas K. Akmatov et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort
Guillaume Moulis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP)
Ombeline Roche et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis
Guillaume Moulis et al.
AUTOIMMUNITY REVIEWS (2016)
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
Matthieu Mahevas et al.
BLOOD (2016)
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
Lamiae Grimaldi-Bensouda et al.
HAEMATOLOGICA (2016)
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
Lamiae Grimaldi-Bensouda et al.
HAEMATOLOGICA (2016)
Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies
Mehdi Khellaf et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
Nancy Agmon-Levin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis
Katja M. J. Heitink-Polle et al.
BLOOD (2014)
A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura
Salah Yousef Abbasi et al.
ANNALS OF HEMATOLOGY (2008)
Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura
Abdullah Altintas et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2007)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
